Mutations in GFAP Alter Early Lineage Commitment of Organoids

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics

Background:

• Glial fibrillary acidic protein (GFAP) is primarily found in astrocytes and is implicated in Alexander disease (AxD) pathogenesis.
• The precise mechanisms by which mutant GFAP leads to white and gray matter degeneration in AxD are not fully understood.
• GFAP expression is also observed in neural precursor cells during brain development.

Purpose of the Study:

• To investigate the role of mutant GFAP during neurodifferentiation using induced pluripotent stem cells (iPSCs) derived from AxD patients.
• To explore the impact of GFAP mutations on early neurodevelopmental processes.

Main Methods:

• Utilized patient-derived induced pluripotent stem cells (iPSCs) from Alexander disease (AxD) patients.
• Examined GFAP expression in iPSCs and during subsequent neurodifferentiation.
• Assessed the effects of GFAP mutations on neural organoid development and lineage commitment in embryoid bodies.

Main Results:

• Glial fibrillary acidic protein (GFAP) expression was detected even in the undifferentiated iPSCs.
• Mutations in GFAP were found to significantly disrupt neural organoid development.
• Altered lineage commitment in embryoid bodies was observed in the presence of GFAP mutations.

Conclusions:

• GFAP plays a crucial role in the early stages of neurodevelopment.
• Mutant GFAP can profoundly affect neural development, starting from the iPSC stage.
• These findings highlight GFAP as an early modulator of neurodevelopmental processes.